NYU/Bellevue WTC Health Impacts Research Registry
The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes,
| Condition(s) | Exposure to World Trade Center Dust |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial spaces, and c) responders to the WTC collapse. These populations are recruited from past and ongoing programs that we have developed as well as from ongoing collaborations with community organizations that include: the Beyond Ground Zero Network, 9/11 Environmental Action committee, and the WTC Residents Coalition. In addition, there is collaboration with the Charles B. Wang Community Health Center and |
| Who can participate | Target populations who will participate in the Bellevue Hospital Red Cross WTC Health Impacts Program will include: * residents (children and adults) of Lower Manhattan communities at the time of the attacks, who remained or returned to their homes soon after the attacks * individuals involved in debris removal in surrounding commercial and residential buildings, * individuals involved in rescue, recovery and debris removal who have been previously screened through the World Trade Center Worker and Volunteer Medical Screening Program and are in need of continued treatment. |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | NYU Langone Health |
| Locations | New York, New York, United States |
| Start date | 2007-12 |
| NCT ID | NCT00404898 |
| Official listing | https://clinicaltrials.gov/study/NCT00404898 |